§ 216b-402

216B.402 Protocol for treatment of drug overdose -- Cannabinoid hyperemesis syndrome. (1) When a person is admitted to a hospital emergency department or hospital emergency room for treatment of a drug overdose: (a) The person shall be informed of av ailable substance use disorder treatment services known to the hospital that are provided by that hospital, other local hospitals, the local community mental health center, and any other local treatment programs licensed pursuant to KRS 222.231; (b) The ho spital may obtain permission from the person when stabilized, or the person's legal representative, to contact any available substance use disorder treatment programs offered by that hospital, other local hospitals, the local community mental health center , or any other local treatment programs licensed pursuant to KRS 222.231, on behalf of the person to connect him or her to treatment; and (c) The local community mental health center may provide an on -call service in the hospital emergency department or ho spital emergency room for the person who was treated for a drug overdose to provide information about services and connect the person to substance use disorder treatment, as

mergency department or ho spital emergency room for the person who was treated for a drug overdose to provide information about services and connect the person to substance use disorder treatment, as funds are available. These services, when provided on the grounds of a hospital, s hall be coordinated with appropriate hospital staff. (2) When a person, who is a registered qualified patient or a visiting qualified patient as defined in KRS 218B.010, is admitted to a hospital emergency department or a hospital emergency room for treatm ent of cannabinoid hyperemesis syndrome, the hospital shall notify the cabinet within forty -eight (48) hours. Notification shall include the registered qualified patient's or a visiting qualified patient's name and registry identification card number, if a vailable. The cabinet shall record all cases of cannabinoid hyperemesis syndrome in the electronic monitoring system established pursuant to KRS 218A.202. Effective: June 29, 2023 History: Amended 2023 Ky. Acts ch. 146, sec. 33, effective June 29, 2023. -- Created 2015 Ky. Acts ch. 66, sec. 7, effective March 25, 2015.